Ally Bridge Group (NY) LLC
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 93% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
26 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $123,814,171 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | +1,033,459 | 2,818,459 | $6,256,978 | |
| SLDB | Solid Biosciences Inc. | +353,349 | 766,974 | $5,522,212 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | +262,480 | 660,375 | $4,781,115 | |
| SLNO | Soleno Therapeutics Inc | +231,971 | 400,000 | $13,392,000 | |
| PMN | ProMIS Neurosciences Inc. | +164,880 | 414,219 | $5,260,581 | |
| QURE | uniQure N.V. | +100,000 | 300,000 | $4,905,000 | |
| PRAX | Praxis Precision Medicines, Inc. | +12,928 | 32,810 | $10,571,053 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | −953,100 | 246,900 | $1,888,785 | |
| IVA | Inventiva S.A. | −754,700 | 745,300 | $4,136,415 | |
| EWTX | Edgewise Therapeutics, Inc. | −284,000 | 161,000 | $5,071,500 | |
| CMPS | COMPASS Pathways plc | −55,000 | 1,045,000 | $5,778,850 | |
| ABVX | Abivax S.A. | −36,288 | 33,712 | $3,753,831 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | 80,859 | $5,672,258 | |
| CMPX | Compass Therapeutics, Inc. | 1,000,000 | $5,290,000 | |
| CTMX | CytomX Therapeutics, Inc. | 900,000 | $4,230,000 | |
| CATX | Perspective Therapeutics, Inc. | 926,557 | $3,863,742 | |
| ALMS | Alumis Inc. | 166,959 | $3,678,106 | |
| URGN | UroGen Pharma Ltd. | 202,124 | $3,634,189 | |
| CAPR | Capricor Therapeutics, Inc. | 113,899 | $3,462,529 | |
| MAZE | Maze Therapeutics, Inc. | 100,000 | $2,985,000 | |
| IKT | Inhibikase Therapeutics, Inc. | 1,325,000 | $2,226,000 | |
| ANTX | AN2 Therapeutics, Inc. | 526,315 | $1,799,997 | |
| RLMD | Relmada Therapeutics, Inc. | 210,525 | $1,465,254 | |
| KPTI | Karyopharm Therapeutics Inc. | 250,000 | $1,392,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | 957,132 | $5,264,226 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SLNO |
Soleno Therapeutics Inc
PUT
+ SHARES
Healthcare
|
Added | 400,000 | $13,392,000 | 10.82% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 32,810 | $10,571,053 | 8.54% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Held | 1,655,500 | $9,974,387 | 8.06% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Added | 2,818,459 | $6,256,978 | 5.05% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Reduced | 1,045,000 | $5,778,850 | 4.67% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
NEW | 80,859 | $5,672,258 | 4.58% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 766,974 | $5,522,212 | 4.46% | |
| CMPX |
Compass Therapeutics, Inc.
CALL
Healthcare
|
NEW | 1,000,000 | $5,290,000 | 4.27% | |
| PMN |
ProMIS Neurosciences Inc.
Healthcare
|
Added | 414,219 | $5,260,581 | 4.25% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 161,000 | $5,071,500 | 4.10% | |
| QURE |
uniQure N.V.
CALL
Healthcare
|
Added | 300,000 | $4,905,000 | 3.96% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Added | 660,375 | $4,781,115 | 3.86% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
NEW | 900,000 | $4,230,000 | 3.42% | |
| IVA |
Inventiva S.A.
Healthcare
|
Reduced | 745,300 | $4,136,415 | 3.34% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
NEW | 926,557 | $3,863,742 | 3.12% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 33,712 | $3,753,831 | 3.03% | |
| ALMS |
Alumis Inc.
Healthcare
|
NEW | 166,959 | $3,678,106 | 2.97% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
NEW | 202,124 | $3,634,189 | 2.94% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
NEW | 113,899 | $3,462,529 | 2.80% | |
| MAZE |
Maze Therapeutics, Inc.
CALL
Healthcare
|
NEW | 100,000 | $2,985,000 | 2.41% | |
| WHWK |
Whitehawk Therapeutics, Inc.
Healthcare
|
Held | 817,939 | $2,821,889 | 2.28% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
NEW | 1,325,000 | $2,226,000 | 1.80% | |
| REPL |
Replimune Group, Inc.
CALL
Healthcare
|
Reduced | 246,900 | $1,888,785 | 1.53% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
NEW | 526,315 | $1,799,997 | 1.45% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 210,525 | $1,465,254 | 1.18% | |
| KPTI |
Karyopharm Therapeutics Inc.
CALL
Healthcare
|
NEW | 250,000 | $1,392,500 | 1.12% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.